Anti-RANKL therapy--implications for the bone-vascular-axis in CKD? Denosumab in post-menopausal women with low bone mineral density.
Westenfeld
Ralf
R
Department of Nephrology and Clinical Immunology, University Hospital Aachen, Pauwelsstrasse 30, D-52057 Aachen, Germany. ralf.westenfeld@rwth-aachen.de
Ketteler
Markus
M
Brandenburg
Vincent M
VM